- Home
- RTO vs ICLR Comparison
RTO vs ICLR Comparison
Compare RTO & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RTO
- ICLR
- Stock Information
- Founded
- RTO 1925
- ICLR 1990
- Country
- RTO United Kingdom
- ICLR Ireland
- Employees
- RTO N/A
- ICLR N/A
- Industry
- RTO Business Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- RTO Consumer Discretionary
- ICLR Health Care
- Exchange
- RTO Nasdaq
- ICLR Nasdaq
- Market Cap
- RTO 12.2B
- ICLR 11.4B
- IPO Year
- RTO N/A
- ICLR 1998
- Fundamental
- Price
- RTO $23.78
- ICLR $130.28
- Analyst Decision
- RTO Hold
- ICLR Buy
- Analyst Count
- RTO 1
- ICLR 12
- Target Price
- RTO N/A
- ICLR $204.18
- AVG Volume (30 Days)
- RTO 541.5K
- ICLR 1.6M
- Earning Date
- RTO 07-25-2025
- ICLR 07-23-2025
- Dividend Yield
- RTO 2.46%
- ICLR N/A
- EPS Growth
- RTO N/A
- ICLR 11.53
- EPS
- RTO 0.15
- ICLR 9.19
- Revenue
- RTO $6,805,463,398.00
- ICLR $8,192,621,999.00
- Revenue This Year
- RTO $15.25
- ICLR N/A
- Revenue Next Year
- RTO $4.21
- ICLR $2.34
- P/E Ratio
- RTO $30.98
- ICLR $14.18
- Revenue Growth
- RTO 1.14
- ICLR N/A
- 52 Week Low
- RTO $19.60
- ICLR $125.10
- 52 Week High
- RTO $34.07
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- RTO 56.61
- ICLR 39.23
- Support Level
- RTO $23.48
- ICLR $125.10
- Resistance Level
- RTO $24.05
- ICLR $132.96
- Average True Range (ATR)
- RTO 0.34
- ICLR 4.34
- MACD
- RTO 0.01
- ICLR 0.79
- Stochastic Oscillator
- RTO 76.29
- ICLR 29.63
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.